Upregulation of DNMT1 mediated by HBx suppresses RASSF1A expression independent of DNA methylation

Oncology Reports

Volumn 31, Issue 1, 2014, Pages 202-208

  Qiu, Xuemei ^a   Zhang, Lihua ^b   Lu, Sen ^c   Song, Yunwei ^a   Lao, Yingbin ^a   Hu, Jiaojiao ^a   Fan, Hong ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; DNMT1; Hepatitis B virus X protein; Hepatocellular carcinoma; Ras association domain family 1A

Indexed keywords

DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3B; HEPATITIS B VIRUS X PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSCRIPTION FACTOR SP1; UPSTREAM STIMULATORY FACTOR;

ARTICLE; CELL STRAIN HEPG2; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RASSF1A GENE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HEPATITIS B VIRUS; HUMANS; LIVER; LIVER NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION; UPSTREAM STIMULATORY FACTORS;

EID: 84891950657     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2848     Document Type: Article

References (40)

1. Thorgeirsson SS and Grisham JW: Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31: 339-346, 2002.
2. Merican I, Guan R, Amarapuka D, et al: Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 15: 1356-1361, 2000.
3. Lupberger J and Hildt E: Hepatitis B virus-induced oncogenesis. World J Gastroenterol 13: 74-81, 2007.
4. Wang Y, Cui F, Lv Y, et al: HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology 39: 318-324, 2004.
5. Pfeifer GP and Dammann R: Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry 70: 576-583, 2005.
6. Hu L, Chen G, Yu H and Qiu X: Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma. Hepatol Int 4: 423-432, 2010.
7. Schagdarsurengin U, Wilkens L, Steinemann D, et al: Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene 22: 1866-1871, 2003.
8. Zhong S, Yeo W, Tang MW, Wong N, Lai PB and Johnson PJ: Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Clin Cancer Res 9: 3376-3382, 2003.
9. Bréchot C: Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127 (Suppl 1): S56-S61, 2004.
10. Kim CM, Koike K, Saito I, Miyamura T and Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317-320, 1991.
11. Yu DY, Moon HB, Son JK, et al: Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol 31: 123-132, 1999.
12. Park IY, Sohn BH, Yu E, et al: Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132: 1476-1494, 2007.
13. Tong A, Gou L, Lau QC, et al: Proteomic profiling identifies aberrant epigenetic modifications induced by hepatitis B virus X protein. J Proteome Res 8: 1037-1046, 2009.
14. Zheng DL, Zhang L, Cheng N, et al: Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. J Hepatol 50: 377-387, 2009.
15. Lee JO, Kwun HJ, Jung JK, Choi KH, Min DS and Jang KL: Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene 24: 6617-6625, 2005.
16. INK4A promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis. Exp Mol Pathol 89: 268-275, 2010.
17. Fan H, Zhao Z, Quan Y, Xu J, Zhang J and Xie W: DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721. Eur J Gastroenterol Hepatol 19: 952-961, 2007.
18. Xu J, Fan H, Zhao ZJ, Zhang JQ and Xie W: Identification of potential genes regulated by DNA methyltransferase 3B in a hepatocellular carcinoma cell line by RNA interference and microarray analysis. Yi Chuan Xue Bao 32: 1115-1127, 2005 (In Chinese).
19. Tao Q, Huang H, Geiman TM, et al: Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet 11: 2091-2102, 2002.
20. Kawaguchi Ki, Oda Y, Saito T, et al: DNA hypermethylation status of multiple genes in soft tissue sarcomas. Mod Pathol 19: 106-114, 2006.
21. Dammann R, Li C, Yoon JH, Chin PL, Bates S and Pfeifer GP: Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25: 315-319, 2000.
22. Chen L, Chan THM, Yuan YF, et al: CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Invest 120: 1178-1191, 2010.
23. Yan PS, Shi H, Rahmatpanah F, et al: Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res 63: 6178-6186, 2003.
24. Tommasi S, Dammann R, Zhang Z, et al: Tumor susceptibility of Rassf1a knockout mice. Cancer Res 65: 92-98, 2005.
25. Burbee DG, Forgacs E, Zöchbauer-Müller S, et al: Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93: 691-699, 2001.
26. Hesson L, Bièche I, Krex D, et al: Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene 23: 2408-2419, 2004.
27. Dreijerink K, Braga E, Kuzmin I, et al: The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci USA 98: 7504-7509, 2001.
28. Kuzmin I, Gillespie JW, Protopopov A, et al: The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res 62: 3498-3502, 2002.
29. Chow LS, Lo KW, Kwong J, et al: RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. Int J Cancer 109: 839-847, 2004.
30. Li J, Wang F, Protopopov A, et al: Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. Oncogene 23: 5941-5949, 2004.
31. Fuks F, Burgers WA, Brehm A, Hughes-Davies L and Kouzarides T: DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet 24: 88-91, 2000.
32. Rountree MR, Bachman KE and Baylin SB: DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet 25: 269-277, 2000.
33. Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL and Wolffe AP: DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25: 338-342, 2000.
34. Höller M, Westin G, Jiricny J and Schaffner W: Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev 2: 1127-1135, 1988.
35. Pieper RO, Patel S, Ting SA, Futscher BW and Costello JF: Methylation of CpG island transcription factor binding sites is unnecessary for aberrant silencing of the human MGMT gene. J Biol Chem 271: 13916-13924, 1996.
36. Strunnikova M, Schagdarsurengin U, Kehlen A, Garbe JC, Stampfer MR and Dammann R: Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter. Mol Cell Biol 25: 3923-3933, 2005.
37. Sawadogo M and Roeder RG: Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell 43: 165-175, 1985.
38. Luo X and Sawadogo M: Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains. Mol Cell Biol 16: 1367-1375, 1996.
39. Roy AL, Du H, Gregor PD, Novina CD, Martinez E and Roeder RG: Cloning of an inr-and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1. EMBO J 16: 7091-7104, 1997.
40. Majumder S, Ghoshal K, Li Z, Bo Y and Jacob ST: Silencing of metallothionein-I gene in mouse lymphosarcoma cells by methylation. Oncogene 18: 6287-6295, 1999.